A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a ...
Please provide your email address to receive an email when new articles are posted on . An AI model showed tumor size to be an independent risk factor for prostate cancer metastasis and recurrence. AI ...
In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...
For prostate cancer patients with low-volume tumors and metastasis, the median overall survival was 37.13 months. Prostate cancer patients with metastatic disease and low-volume primary tumors appear ...
Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results